Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-21-000022 General Corporate
Debt relative to revenue 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
170.33% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.63% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.29% · OPTIONAL · VALID
Revenue growth 85th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
8.57% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
69.79% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.19% · CORE · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.74% · CORE · VALID
R&D intensity 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.48% · OPTIONAL · VALID
SBC intensity 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.67% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 170.15%
Current 170.33%
Delta 0.18% Capex Intensity Increased
Previous 1.49%
Current 1.63%
Delta 0.14% Cash Generation Increased
Previous 12.08%
Current 17.29%
Delta 5.21% Growth Decreased
Previous 12.99%
Current 8.57%
Delta -4.42% Inventory Pressure Decreased
Previous 71.87%
Current 69.79%
Delta -2.08% Margin Increased
Previous 36.16%
Current 38.19%
Delta 2.03% Profitability Increased
Previous 15.22%
Current 15.74%
Delta 0.52% R And D Intensity Decreased
Previous 3.73%
Current 3.48%
Delta -0.25% Sbc Intensity Increased
Previous 0.55%
Current 0.67%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.